REFERENCES

Abrahamsson, P.A., L.B. Wadstrom, J. Aluments, S. Falkmer, and L. Grimelius. 1987. Peptide-hormone-and serotonin-immunoreactive tumor cells in carcinoma of the prostate. Pathol. Res. Pract. 182:298–307.

Abrahamsson, P.A., S. Falkmer, K. Falt, and L. Grimelius. 1989. The course of neuroendorcrine differentiation in prostatic carcinomas. An immunohistochemical study testing chromogranin A as an endocrine marker. Pathol. Res. Pract. 185:373–380.

Acara, M.A., R.J. Mazurchuk, P.A. Nickerson, and R.J. Fiel. 1991. Magnetic resonance imaging and histopathology of hydronephrosis in the rat. Magnetic Resonanace Imaging 9:89–92.

Akaza, H., S. Kameyama, and Y. Aso. 1987. Significance of tumor markers in the treatment of urological malignancies [in Japanese]. Gan to Kagaku Ryoho 14:3034–3040.

Åkerström, B., and L. Lögdberg. 1990. An intruguing member of the lipwcalin protein family: α1-microglobin. Trends Biochem. Sci. 15:240–243.

Akimoto, S., K. Akakura, and J. Shimazaki. 1988. Prostatic acid phosphatse (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer [in Japanese], Hinyokika Kiyo (Acta. Urol. Jpn.) 34:1389–1396.

al-Abadi, H., and R. Nagel. 1988. Prognostic relevance of ploidy and proliferative activity of renal cell carcinoma. Eur. Urol. 15:271–276.

Alden, C.L. 1986, A review of unique male rat hydrocarbon nephropathy. Toxicol. Pathol. 14:109–111.

Alden, C.L. 1989. Male rat specific alpha2u globulin nephropathy and renal tumorigenesis. Pp. 535–541 in Nephrotoxicity. In Vitro to In Vivo. Animals to Man. P.H. Bach, and E.A. Lock, eds. New York: Plenum Press.

Alden, C.L., and C.H. Frith. 1991. Urinary system. Pp 315 in Handbook of Toxicologic Pathology, W.M. Haschek, and C.G. Rousseaux, eds. San Diego: Academic Press.

Alden, C.L., R.L. Kanerva, G. Ridder, and L.C. Stone. 1984. The pathogenesis of the nephrotoxocity of volatile hydrocarbons in the male rat. Pp. 107–120 in Advances in Modern Environmental Toxicology. Vol. III. Renal Effects of Petroleum



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 227
Biologic Markers in Urinary Toxicology REFERENCES Abrahamsson, P.A., L.B. Wadstrom, J. Aluments, S. Falkmer, and L. Grimelius. 1987. Peptide-hormone-and serotonin-immunoreactive tumor cells in carcinoma of the prostate. Pathol. Res. Pract. 182:298–307. Abrahamsson, P.A., S. Falkmer, K. Falt, and L. Grimelius. 1989. The course of neuroendorcrine differentiation in prostatic carcinomas. An immunohistochemical study testing chromogranin A as an endocrine marker. Pathol. Res. Pract. 185:373–380. Acara, M.A., R.J. Mazurchuk, P.A. Nickerson, and R.J. Fiel. 1991. Magnetic resonance imaging and histopathology of hydronephrosis in the rat. Magnetic Resonanace Imaging 9:89–92. Akaza, H., S. Kameyama, and Y. Aso. 1987. Significance of tumor markers in the treatment of urological malignancies [in Japanese]. Gan to Kagaku Ryoho 14:3034–3040. Åkerström, B., and L. Lögdberg. 1990. An intruguing member of the lipwcalin protein family: α1-microglobin. Trends Biochem. Sci. 15:240–243. Akimoto, S., K. Akakura, and J. Shimazaki. 1988. Prostatic acid phosphatse (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer [in Japanese], Hinyokika Kiyo (Acta. Urol. Jpn.) 34:1389–1396. al-Abadi, H., and R. Nagel. 1988. Prognostic relevance of ploidy and proliferative activity of renal cell carcinoma. Eur. Urol. 15:271–276. Alden, C.L. 1986, A review of unique male rat hydrocarbon nephropathy. Toxicol. Pathol. 14:109–111. Alden, C.L. 1989. Male rat specific alpha2u globulin nephropathy and renal tumorigenesis. Pp. 535–541 in Nephrotoxicity. In Vitro to In Vivo. Animals to Man. P.H. Bach, and E.A. Lock, eds. New York: Plenum Press. Alden, C.L., and C.H. Frith. 1991. Urinary system. Pp 315 in Handbook of Toxicologic Pathology, W.M. Haschek, and C.G. Rousseaux, eds. San Diego: Academic Press. Alden, C.L., R.L. Kanerva, G. Ridder, and L.C. Stone. 1984. The pathogenesis of the nephrotoxocity of volatile hydrocarbons in the male rat. Pp. 107–120 in Advances in Modern Environmental Toxicology. Vol. III. Renal Effects of Petroleum

OCR for page 227
Biologic Markers in Urinary Toxicology Hydrocarbons. M.A. Mehlman, G.P. Hemstreet, J.J. Thorpe, and N.K. Weaver, eds. Princeton: Princeton Scientific Publishers, Inc. Aleo, M.D., and R.G. Schnellman, 1992a. The neurotoxicants strychnine and biculline protect renal proximal tubules from mitochondrial inhibitor-induced cell death. Life Sci. 51:1783–1787. Aleo, M.D., and R.G. Schnellman. 1992b. Regulation of glycolytic metabolism during long-term primary culture of renal proximal tubule cells. Am. J. Physiol. 262:F77F85. Aleo, M.D., M.L. Taub, P.A. Nickerson, and P.J. Kostyniak. 1989. Primary cultures of rabbit renal proximal tubule cells: I. Growth and biochemical characteristics. In Vitro Cell. Dev. Biol. 25:776–783. Alfrey, A.C., and R.C. Tomford. 1982. Phosphate and prevention of renal failure. Pp. 31–38 in Prevention of Kidney Disease and Long-Term Survival, M.M. Avram, ed. New York: Plenum. Allen, B.C., and J.W. Fisher. 1993. Pharmacokinetic modeling of trichloroethylene and trichloroacetic acid in humans. Risk Analysis 13:71–86. Allen, B.C., K.S. Crump, and A.M. Shipp. 1988. Correlation between carcinogenic potency of chemicals in animals and humans. Risk Anal. 8:531–544. Allen, J.K., E.A. Krauss, and E.G. Deeter. 1991. Dipstick analysis of urinary protein. A comparison of Chemstrip-9 and Multistix-10SG. Arch. Path. Lab. Med. 115:34–37. Allison, M.E., E.M. Lipham, W.E. Lassiter, and C.W. Gottschalk. 1973. The acutely reduced kidney. Kidney Int. 3:354–363. Almeder, R. and J. Humber. 1987. Introduction to Quantitative Risk Assessment. Biomedical Ethics Reviews, 1986. J. Humbar, R. Almeder, eds. Clifton, N.J.: Humana Press. Almeida, A.R.P., D. Bunnachak, M. Burnier, J.F.M. Wetzels, T.J. Burke, and R.W. Schrier. 1992. Time-dependent protective effects of calcium channel blockers on anoxia and hypoxia-induced proximal tubule injury. J. Pharmacol. Exp. Ther. 260:526–532. Ambrose, S.S. 1983. Ureterosigmoidostomy. Pp. 511–520 in Urologic Surgery, 3rd edition, J.F. Glenn, ed. Philadelphia: Lippincott. Ambrurn, J.L., C.M. Ambrus, P. Forgach, S. Stadler, J. Haplern, S. Sayyid, P. Niswander, and C. Toumbis. 1992. Studies on tumor induced angiogenesis. EXS 61:436–444. Ames, B.N., and L.S. Gold. 1990. Too many rodent carcinogens: Mitogenesis increases mutagenesis. Science 249:970–971. Amico, S., J.C. Liehn, B. Desoize, H. Larbre, G. Deltour, and J. Valeyre. 1991 Comparison of phophotase isoenzymes PAP and PSA with bone scan in patients with prostate carcinoma. Clin. Nucl. Med. 16:643–648. Anders, M.W. 1980 Metabolism of drugs by kidney. Kidney Int. 18:636–647.

OCR for page 227
Biologic Markers in Urinary Toxicology Anders, M.W., ed. 1985. Bioactivation of Foreign Compounds. New York: Academic Press. Anders, M.W. 1989. Biotransformation and bioactivation of xenobiotics by the kidney. Pp. 81–97 in Intermediary Xenobiotic Metabolism in Animals: Methodology, Mechanisms and Significance. D.H. Hutson, J. Caldwell, and G.D. Paulson, eds. London: Taylor & Francis. Anders, M.W., L.H. LAsh, W. Dekant, A.A. Elfarra, and D.R. Dohn. 1988 Biosynthesis and metabolism of glutathione conjugates to toxic forms. CRC Crit. Rev. Toxicol. 18:311–341. Anderson, R.L. 1985. Some changes in gastro-intestinal metabolism and in the urine and bladders of rats in responce to sodium saccharin ingestion. Fd. Chem. Toxic 23:457–463. Anderson, R.L. 1988. An hypothesis of the mechanism of urinary tumorigenesis in rats ingesting sodium sacchrin. Fd. Chem. Toxic 26:637–644. Anderson, R.L. 1991. Early indicators of bladder carcinogenesis produced by non-genotoxic agents. Mut. Res. 248:261–270. Anderson, R.L., and C.L. Alden. 1989. Risk assessment for nitrilotriacetic acid (NTA). Pp. 390–426 in The Risk Assessment of Environmental Hazards. A Textbook of Case Studies. D.J. Paustenbach, ed. New York: John Wiley & Sons. Anderson, P.M., and M.O. Schultze. 1965. Cleavage of S-(1,2-dichlorovinyl)-L-cysteine by and enzyme of bovine origin. Arch. Biochem. Biophys. 111:593–602. Anderson, E., and the Carcinogen Assessment Group of the U.S. Environmental Protection Agency. 1983. Quantitative approaches in use to assess cancer risk. Risk Analysis 3:277–295. Anderson, R.L., W.E. Bishop, and R.L. Campbell. 1985. A review of the environmental and mammalian toxicology of nitrolotriacetic acid. CRC Crit. Rev. Toxicol. 15:1–102. Anderson, R.L., R.L. Kanerva, F.R. Lefever, and W.R. Francis. 1986a. Effect of N-nitrose-n-butyl-(4-hydroxybutyl)amine exposure on the changes in mineral deposition caused by trisodium nitrilotriacetate. Fd. Chem. Toxic 24:229–235. Anderson, S., H.G. Rennke, and B.M. Brenner. 1986b. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J. Clin. Invset. 7:1993–2000. Anderson, R.L., F.R. Lefever, and J.K. Maurer. 1988. The effect of various sacchrin forms on gastro-intertinal tract, urine and bladder on male rats. Fd. Chem. Toxic. 26:665–669. Andersson, G., and E. Jennische. 1988. IGF-I immunoreactivity is expressed by regenerating renal tubular cells after ischaemic injury in the rat. Acta. Physiol. Scand. 132:4653–457. Andersson, G.L., A. Skottner, and E. Jennische. 1988. Immunocytochemical and

OCR for page 227
Biologic Markers in Urinary Toxicology biochemical localization of insulin-like growth factor I in the kidney of rats before and after uninephrectomy. Acta. Endocrinol. 119:555–560. Anglard, P., K. Tory, H. Brauch, G.H. Weiss, F. Latif, M.J. Merino, M.I. Lerman, B. Zbar, and W.M. Linehan. 1991. Molecular analysis of genetic changes in the origin and development of renal cell carcinoma. Cancer Res. 51:1071–1077. Annab, L.A., J.T. Dong, P.A. Futreal, H. Satoh, M. Oshimura, and J.C. Barrett. 1992. Growth and transformation suppressor genes for BHK Syriam hamster cells on human chromosomes 1 and 11. Mol. Carcinog. 6:280–288. Anonymous. 1985. Acid phosphatases and other tumor markers in the management of prostatic cancer. Proceedings of the Workshop of the Scandinavian Prostatic Cancer Group, Scandinavian Committee on Enzymes. Copenhagen, March 1985. Scand. J. Clin. Lab. Invest. Suppl. 179:1–117. Anonymous. 1990. Bladder cancer screening in high-risk groups. Proceedings of the International Conference. September 13–14, 1989. J. Occup. Med. 32:787–945. Arndt, R. J. Durkopf, H. Huland, F. Donn, T. Loening, and H. Kalthoff. 1987. Monoclonal antibodies for characterization of the heterogeneity of normal and malignant transitional cells. J. Urol. 137:758–763. Ash, S.R., and F.E. Cuppage. 1970. Shift toward anaerobic glycolysis in the regererating rat kidney. Am. J. Pathol. 60:385:402. Askergren, A., L.G. Allgen, and J. Berstrom. 1981. Studies on kidney function in subjects exposed to organic solvents. 1. Excretion of albumin and beta2-microglobulin in the urine. Acta. Med. Scand. 209:479–483. Askergren, A. 1984. Urinary protein and cell excretion in constructions workers exposed to organic solvents. Asselin, C., and K.B. Marcus. 1989. Mode of c-myc gene regulation in folic acid-induced kidney regeneration. Oncogene Res. 5:67–72. Aten, J., C.B. Bosman, J. Rozing, T. Stynen, P. Hoedemacker, and J.J. Weening. 1988. Mercuric chloride-induced autoimmunity in the Brown Norway Rat. Am. J. Path. 133:127–138. Aulizky, W.K., P.N. Schlogel, D. Wu, C.Y. Cheng, C.C. Chen, P.S. Li, M. Goldstein, M. Reidenberg, and C.W. Bardin. 1992. Measurement of urinary clusterin as an index of nephrotoxicity. Proc. Soc. Exp. Biol. Med. 199:93–96. Azzopardi, J.G., and D.J. Evans. 1971. Argentaffin cells in prostatic carcinoma: Differentiation from lipofuscin and melanin in prostatic epithelium. J. Pathol. 104:247–251. Baisch, H., U. Otto, and G. Kloppel. 1986. Malignancy index based on flow cytonetry and histology for renal cell carcinomas and its correlation to prognosis. Cytometry 7:200–204. Baisch, H., G. Kloppel, and U. Otto. 1990. Pp. 249–260 in DNA analysis in relan neoplasia. New York: Churchill Livingstone. Balitskaia, O.V., N.K. Berdinskikh, and N.G. Kononenko. 1992. The possibilities of

OCR for page 227
Biologic Markers in Urinary Toxicology using the free polyamines of the peripheral blood as biochemical tumor markers in nephroblastoma in children [in Russian]. Vopr. Onkol. 38:674–682. Ballardi, F.W., ed. 1992. Autoimmunity in Nethritis. Chur, Switzerland: Harwood Academic Publishers. Ballatori, N., R. Jacob, C. Barrett, and J.L. Boyer. 1988. Biliary catabolism of glutathione and differential reabsorption of its amino acids constituents. Am. J. Physiol. 254:G1–G7. Bander, N.H., C.L. Finstad, C. Cordon-Cardo, R.D. Ramsawak, E.D. Vaughan, W.F. Whitmore, H.F. Oettgen, M.R. Melames, and L.J. Old. 1989. Analysis of a mouse monoclonal antibody that reacts with a specific region of the human proximal tubule and subsets renal cell carcinomas. Cancer Res. 49:6774–6780. Bandyk, M., I. Sawczuk, C.A. Olsson, A.E. Katz, and R. Buttyan. 1990. Characterization of the products of a gene expressed during androgen-programmed cell death and their potential use as a marker of urogenital injury. Banki, K., and M.W. Anders. 1989. Inhibition of rat kidney mitochondrial DNA, RNA and protein synthesis by halogenated cystein S-conjugates. Carcinogenesis 10:767–772. Baretton, G., B. Kuhlmann, R. Krech, U. Lohrs. 1991. Intratumoural heterogeneity of nuclear DNA-content and proliferation in clear cell type carcinomas of the kidney. Virchows Arch B: Cell Pathol. Mol. Pathol. 61:57–63. Baricordi, O.R., A. Sensi, C. DeVinci, L. Melchorri, G. Fabris, E. Marchette, F. Corrado, P.L. Mattiuz, and G. Pizza. 1985. A monoclonal antibody to human transitional cell carcinoma of the bladder cross reaction with a differentiation antigen of neutrophilic lineage. Int. J. Cancer 35:781–786. Barrett, J.C., and J.E. Huff. 1991. Cellular and molecular mechanisms of chemically induced renal cancinogenesis in nephretoxicity. Pp. 287–306 in Mechanisms, Early Diagnosis, and Therapeutic Management . P.H. Bach, N.J. Gregg, M.F. Wiks, and L. Delactuz, eds. New York: Marcel Dekker, Inc. Balslov, J.T., and H.E. Jorgensen. 1963. A survey of 499 patients with acute anuric renal insufficience. Causes, treatment, complications, and mortality. Am. J. Med. 34:75. Bass, R.A., G. Hemstreet, N.A. Honker, R.E. Hurst, R.S. Doggett. 1987. DNA cytometry and cytology by quantitative fluorescence inage analysis in sympltomatic bladder cancer patients. Int. J. Cancer 40(5):698–705. Basta, M.T., A.M. Attallah, M.N. Seddek, H. el-Mohamady, E.S. Al-Hilaly, N. Atwaan, and M. Ghoneim. 1988. Cytokeratin shedding in urine: A biological marker for bladder cancer? Br. J. Unol. 61:116–121. Bauer, H.W. 1988. Acid phosphatase, alkaline phosphatase and prostate-specific antigen—usefulness in the diagnosis of netastatic disease and follow-up. Prog. Clin. Biol. Res. 269:33–42. Bauer, D., Müller, J. Reich, H. Riedel, V. Ahrenkiel, P. Warthoe, and M. Strauss.

OCR for page 227
Biologic Markers in Urinary Toxicology 1993. Indentification of differentially expressed mRNA species by an improver display technique (DDRT-PCR). Nucleic Acids Res. 21:4272–4280. Beckett, M.L., G.B. Lipford, C.L. Haley, P.F. Schellhammer, and G.L. Wright. 1991. Monoclonal antibody PD41 recognizes and antigen restricted to prostate adencarcinomas. Cancer Res. 51:1326–1333. Beer, D.G., K.A. Zweifel, D.P. Simpson, and H.C. Pitot. 1987. Specific gene expression during compensatory renal hypertrophy in the rat. J. Cell Physiol. 131:29–35. Beggard, I., and A.G. Bearn. 1968. Isolation and properties of a low molecular weight β2-globulin occuring in human biological fluids. J. Biol. Chem. 243:4095–4103. Bethrens, M.T., A.L. Corbin, and M.K. Hise. 1989. Epidermal growth factor receptor regulation in rat kidney: Two models of renal growth. Am. J. Physiol. 257:4095–4103. Beirne, G.J., J.T. Brennan. 1972. Glomerulonephritis associated with hydrocarbon solvents. Arch. Environ. Health 24:365–369. Bell, G.M., D. Doig, D. Thompson, J.L. Anderton, and J.S. Robson. 1985. End-stage renal disease associated with occupational exposure to organic solvent. Proc EDTA-ERA 22:725–729. Bell, G.I., N.M. Fong, M.M. Stempien, M.A. Wormsted, D. Caput, L. Ka, M.S. Urdea, L.B. Rall, and R. Sanchez-Pescador. 1986. Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization. Nucleic Acids Res. 14:8427–8446. Ben-Aissa, H., S. Paulie, and H. Koho. 1985. Specificities and binding properties of two monoclonal antibodies against carcinoma cells of the human urinary bladder. Br. J. Cancer 52:65–72. Bennett, W.M., L.W. Elzinga, and G.A. Porter. 1991 Tubulointerstitial disease and toxic nephropathy. Pp. 1430–1496 in the Kidney. B.M. Brenner, F.C. Rector, and W.B. Saunders, eds. Philadelphia, London, Toronto, Montreal, Sydney, Tokyo. Bennington, J.K., and J.B. Beckwith. 1975. Tumors of the Kidney, Renal Pelvis, and Ureter. Pp. 93–199 in Atlas of Tumor Pathology. Second Series, Fascicle 12. Washington, D.C.: Armed Forces Institute of Pathology. Benson, M.C., I.S. Whang, C.A. Olsson, D.J. McMahon, And W.H. Cooner. 1992a. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J. Urol. 147:813–821. Benson, M.C., I.S. Whang, A. Pantuckk, K. Ring, S.A. Kaplan, C.A. Olsson, and W.H. Cooner. 1992b. Prostate specific antigen density: A means of distinuishing benign prostatic hypetrophy and prostate cancer. J. Urol. 147:815–816. Bergerheim, U., M. Nordenskjold, and V.P. Collins. 1989. Deletion mapping in human renal cell carcinoma. Cancer Res. 49:1390–1396. Bergerheim, U.S., K. Kunimi, V.P. Collins, and P. Ekman. 1991. Deletion mapping of

OCR for page 227
Biologic Markers in Urinary Toxicology chromosomes 8, 10, and 16 in human prostatic cancinoma. Genes Chromosom. Cancer 3(3):215–220. Berggard, I. 1970. Plasma proteins in normal human urine. Pp. 7–19 in Proteins in Normal and Pathological Urine. Y. Manuel, J.P. Revillard, and H. Betuel. eds. S. Karger, Basel. Berlyne, G.M. 1984. Toxic nephropathies and current methods for early dection of the toxicity of the kidney. Pp. 173–184 in Renal Effects of Petroleum Hydrocarbons. Advances in Moderm Environmental Toxicology, Vol. VII. M.A. Mehlman, C.P. Hemstreet, J.J. Thorpe, and N.K. Weaver, eds. Princeton: Princeton Scientific Publishers. Berman, J., J. Seidman, R. Yetter, adn G. Moore. 1991. Clear cell dysplasia of the bladded. Report of a case with flow cytometric analysis. Anal. Quant. Cytol. Histol. 13(6):391–394. Bernard, A., A. Vyskocyl, P. Mahieu, and R. Lauwerys. 1988. Effect of renal insufficiency on the concentration of free retinol-binding protein in urine and serum. Clin. Chim. Acta. 171:85–93. Bernard, A.M., R.R. Lauwerys, A. Nöel, B. Vandeleene, and A. Lambert. 1989. Urine protein 1: A sex dependent marker of tubular or glomerular dysfunction. Clin. Chem. 35:2141–2142. Berndt, W.O. 1981. Use of renal function tests in the evaluation of nephrotoxic effects. Pp. 1–29 in Toxicology of the Kidney, J.B. Hook, ed. New York: Raven. Berrozpe, G., R. Miro, M.R. Caballin, J. Salvador, and J. Egozcue. 1990. Trisomy 7 may be a primary change in noninvasive transitional cell cancinoma of the bladded. Cancer Genet. Cytogenet. 50:9–14. Bertani, T., M. Livio, D. Maconi, M. Morigi, G. Bisogno, C. Patrono, and G. Remuzzi. 1987. Platelet activating factor (PAF) as the mediator of injury in nephrotoxic nephritis. Kidney Int. 31:1248–1256. Bi, W., J.Y. Rao, G.P. Hemstreet P. Fang. N.R. Asal, M. Zang, K.W. Min , Z. Ma, P. Fang, E. Lee, G. Li, R.E. Hurst, W. Wu, R.B. Bonner, Y. Wang, Y. Fradet, and S. Yin. 1993. Field molecular epidemiology: Feasibility of monitering for the malignant bladder cell phenotype in a benzidine exposed occupational cohort. J. Occup. Med. 35(1):20–27. Birk, H.W., S. Piberhofer, G. Schutterle, W. Haase, J. Kotting, and H. Koepsell. 1991. Analysis of Na+-D-glucose cotransporter and other renal brush border proteins in human urine. Kidney Int. 40:823–837. Blais, A., F. Jalal, P. Crine, J. Paiement, and A. Bertloot. 1992. Increased functional differentiation of rabbit proximal tubule cells cultured in glucose-free media. Am. J. Physiol. 263:F152–F162. Blay, J.Y., S. Negrier. V. Combaret, S. Attali, E. Goillot, Y. Merrouche, A. Mercatello, A. Ravault, J.M. Tourani, J.F. Moskovtchenko, T. Phillip, and M. Favrot. 1992.

OCR for page 227
Biologic Markers in Urinary Toxicology Serum level of interieukin 6 as a prognosis factor in metastatic renal cell cercinoma. Cancer Res. 52:3317–3322. Blouin, P., M.C. Guiot, and S. Jothy. 1989. Definition of the human renal cell carcinoma phenotype using monoclonal and polyclonal antibodies: A tumor marker study. Exp. Pathol. 36:147–163. Boag, A.H., and I.D. Young. 1992. Type IV collagenase expression in prostatic adenocarcinoma [abstract]. Mad. Pathol. 5:51A. Bodenstab, W., J. Kaufman, and C.L. Parsons. 1983. Inactivation of antoadherence effect of bladder surface glycusaminoglycan by a complete urinary carcinogen (N-methyl-N-nitrosourea). J. Urol. 129. Boehm, T., I. Lavenir, A. Forster, R.B. Wadey, J.K. Cowell, J. Harbott, F. Lampert, J. Waters, P. Sherrington, and P. Couillin. 1988. The T-ALL specific t(11;14)(p13;q11) translocation breakpoint cluster region is locatid near tho the Wilms'tumour prodisposition locus. Oncogene 3:691–695. Boileau, M., D. Swartz, K. Schmidt, and W. Schmidt. 1987. Bladder cancer dection and surceillance: Carcinoembryonic antigen as a monitor of newplastic transformation. J. Surg. Oncol. 35:120–123. Boldog, F., K. Arheden, S. Imreh, B. Strombeck, L. Szekely, R. Erlandsson, Z., Marcsek, J. Sumegi, F. Mitelman, and G. Klein. 1991. Involvement of 3p deletions in sporatic and hereditary forms of renal cell cancinoma. Genes Chromosomes Cancer 3:403–406. Bombassei, G.J., and A. E. Kaplan. 1992. The association between hydrocarbon exposure and antiglomerular basement membrane antibody-mediated disease (Goodpasture's syndrome). Am. J. Indust. Med. 21:141–153. Bonner, R.B., G.P. Hemstreet, Y. Fradet, J.Y. Rao, K.W. Min, and R.E. Hurst. 1993. Bladder cancer risk assessment with quantitative fluoroscence image analysis of tumor markers in exfoliated bladder cells. Cancer 72:2461–2469. Boogaard, P.J., J.N.M. Commandeur, G.J. Mulder, N.P.E. Vermeulen, and J.F. Nagelkerke. 1989. Toxicity of cystein S-conjugates and mercapturic acids of four structurally related difluoroethylenes in isolated proximal tubular cells from rat kidney: Uptake of the conjugates and activation to toxic metabolites. Biochem. Pharmacol. 38:3731–3741. Boogaard, P.J., J.P. Zoeteweij, T.J.C. van Berkel, J.M. van't Noorkende, G.J. Mulder, and J.F. Nagelkerke. 1990. Primary culture of proximal tubular cells from normal rat kidney as an in vitro model to study mechanisms of nephrotoxicity: Toxicity of nephrotoxicants at low concentrations during prolonged exposure. Biochem. Pharmacol. 39:1335–1345. Bookstein, R., D. MacGrogan, S.G. Hilsenbeck, F. Sharkey and D.C. Allred. 1993. p53 is mutated in a subset of advanced-stage prostate cancers. Cancer Res. 53:3369–3373. Borghoff, S.J., B.G. Short, and J.A. Swenberg. 1990. Biochemical mechanisms and

OCR for page 227
Biologic Markers in Urinary Toxicology pathobiology of α2u-giobulin nephropathy. Ann. Rev. Pharmacol. Toxicol. 30:349–367. Borghoff, S.J., A.B. Miller, J.P. Bowen, and J.A. Swenberg. 1991 Characteristics of chemical binding to α2u-globulin in vitro—evaluation structure-activity relationships. Toxicol. Appl. Pharmacol. 107:228–238. Borland, R., C. Brendler, and W.B. Isaacs. 1992. Molecular biology of bladder cancer. Hematol. Oncol. Clin. NorthAm. 6(1):31–39. Bortz, J.D., P. Rotwein, D. DeVol, et al. 1988. Focal expression of insulin-like growth factor I in rat kidney collection duct. J. Cell Biol. 107:811–819. Bostwick, D.G. 1989. The pathology, of early prostate cancer. Cancer J. Clin. 39:376–393. Bostwick, D.G, 1989. Varients of prostatic carcinoma. Pp. 95–133 in Pathology of the Prostate, D.G. Bostwick, ed. New York: Churchill Livingstone. Bostwick, D.G., Graham, P. Napalkov, P.A. Abrahamsson, P.A. di Sant'Agnese, F. Algaba, P.A. Hoisaeter, F. Lee, P. Littrup, and F.K. Mostofi. 1993. Staging of early prostate cancer: A proposed tumor volume-based prognostic index. Urology 41:403–411. Boswell, J.M., M.A. Yui, D.W. Burt, and V.E. Kelley. 1988. Increased tumor necrosis factor and IL-1β gene expression in the kidneys of mice with lupus nephritis. J. Immunol. 141:3050–3054. Bot, F.J., J.C. Godschalk, K.K. Krishnadath, T.H. van der Kwast, and F.T. Bosman. 1994. Prognostic factors in renal-cell carcinoma: Immunohistochemical detection of p53 protein versus clinico-pathological paramenter. Int. J. Cancer 57:634–637. Boucher, A., D. Droz, E. Adafer, and L-H. Noël. 1986. Characterization of mononuclear cellsubsets in renal cellular interstitial infiltrates. Kidney Int. 29:1043–1049/ Boffioux, C.R. 1980. Etiological and epidemiological considerations in prostatic cancer. Scand. J. Urol. Nephrol., Suppl. 55;9–16. Bowers, M.A., L.D. Aicher, H.A. Davis, and J.S. Woods. 1992. Quantitative determination of porphyrins in rat and human urine and evaluation of urinary porphyrin profiles during mercury and lead exposures. J. Lab. Clin. Med. 120:272–281. Boyce, N.W. P.G. Tipping, and S.R. Holdsworth. 1989. Glomerular macrophages produce reactive oxygen species in experimental glomerulonephritis. Kidney Int. 35:778–782. Boyle, E. 1970. Biological patterns in hypertension by race, sex, body weight and skin color. JAMA 213:1637–1643 Brady, H.R. B.C. Kone, M.E. Stromski, M.L. Zeidel, G. Giebisch, and S.R. Gullans. 1990, Mitochondrial injury: An early event in cisplatin toxicity to renal proximal tubules. Am. J. Physiol. 258:F1181–F1187. Brauch, H. K. Tory, W.M. Linehan, D.J. Weaver, M.A. Lovell, and B. Zbar. 1990.

OCR for page 227
Biologic Markers in Urinary Toxicology Molecular analysis of the sort arm of chromosome 3 in five renal oncocytomas. J. Urol. 143:622–624. Braver, D.J., M. Modan, A Chetrit, A. Lucky, and Z. Braf. 1987. Drinking, micturition habits, and urine concentration as potential risk factors in urinary bladder cancer. J. Natl. Cancer Inst. 78:437–440. Brazy, P.C., L.J. Mandel, S.R. Gullans, and S.P. Soltoff. 1984. Interactions between phosphate and oxidative metabolism in proximal renal tubules. Am. J. Physiol. 247:F575–F581. Brenner, B.M., and S. Anderson. 1989. Filtration surface area, salt intake, and hypertension. Pp. 45–59 in The Progressive Nature of Renal Disease: Myths and Facts. Contributions in Nephrology, Vol. 75, L. Oldrizzi, G. Maschio, and C. Rugiu, eds. Basel: Karger. Brenner, B.M., and F.C. Rector, eds. 1986. The Kidney, 3rd edition. Philadelphia: W.B. Saunders Company. Brenner, B.M., T.W. Meyer, and T.H. Hostetter. 1982. Dietary protein intake and the progressive nature of kidney disease. N. Engl. J. Med. 307:652–659. Bretton, P.R., A. Myc, C. Cordon-Cardo, P. DeAngelis, W.R. Fair, and M.R. Melamed. 1989. Initial evaluation of a new epithelial antigen (TI 6) for bivariate flow cytometry of bladder irrigation specimens. Cytometry 10:339–344. Breysse, P., W.G. Couser, C.E. Alpers, K. Nelson, L. Gaur, and R.J. Johnson . 1994. Membranous nephropathy and formaldehyde exposure. Bringuier, P.P., R. Umbas, H.E. Schaafsma, H.F.M. Karthaus, F.M. J. DeBruyne, and J.A. Schalken. 1993. Decreased e-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res. 53:3241–3245. Bringuier, P.P., R. Bouvier, N. Berger, E. Piaton, J.P. Revillard, P. Perrin, and M. Devonec. 1993. DNA ploidy status and DNA content instability within single tumors in renal cell carcinoman. Cytometry 14:559–564. Brochard, P., J. DePalmas, M. Martini, M. Bondet, and G. Largue. 1984. Etude de la prevalence des proteinuries dipistees chex des sujets exposes professionnellment aux solvants. XXI Int. Congr. Occup. Health, Dublin. Broder, L.E., B.D. Weintraub, S.W. Rosen, M.H. Cohen, and F. Tejada. 1977. Placental proteins and their subunits as tumor markers in prostatic carcinoma. Cancer 40:211–216. Brooks, D.E. 1987. The major androgen-regulated secretory proteins of the rat epidiymis bear sequence homology with members of the α 2u-globulin superfamily. Biochem. Int. 14:235–240. Brooks, J.D., G.S. Bova, F.F. Marshall, and W.B. Isaacs. 1993. Tumor suppressor gene allelic loss in human renal cancers. J. Ruol. 150:1278–1283. Bruner, R.H. 1984. Pathologic findings in laboratory animals exposed to hydrocarbon fuels of military interest. Pp. 133–140 in Advances in Modern Environmental Toxicology. Vol. Vii. Renal Effects of Petroleum Hydrocarbons. M.A. Mehlman,

OCR for page 227
Biologic Markers in Urinary Toxicology G.P. Hemstreet, J.J. Thorpe, and N.K. Weaver, eds. Princeton: Princeton Scientific Publishers, Inc. Bucher, N.L.R., and R.A. Malt. 1971. Regeneration of liver and kidney. Boston: Little, Brown. Buchet, J.P., R. Lauwerys, H. Roels, A. Bernard, P. Bruaux, F. Claeys, G. Ducofere, P. De Plaen, J. Staessen, A. Amery, P. Lijnen, L. Thijs, D. Rondia, F. Sartor, A. Saint Remy, and L. Nick. 1990. Renal effects of cadmium body burden of the general populatoin. The Lancet 335:699–762. Bullock, A.D., J.J. Becich, C.G. Klutke, and T.L. Ratliff. 1992. Experimental autoimmune cystitis: A potential murine model for ulcerative interstitial cystitis. J. Urol. 148:1951–1956. Burg, M. b., and M.A. Knepper. 1986. Single ruble perfusion techniques. Kidney Int. 30:166–170. Burns, C.P., and E. Rozengurt. 1984. Extracellular Na+ and initiation of DNA synthesis: Role of intracellular pH and K+. J. Cell Biol. 98:1082–1089. Burton, B.T. and G.H. Hirschman. 1979. Demographic analysis: End-stage renal disease and its treatment in the United States. Clin. Nephrol. 11:47–51. Bussemakers, M.J.G., W.B. Isaacs, B.S. Carter, W. Van de Ven, F.M.J. DeBruyne, and J.A. Schalken. 1991. Ecahedrin is a candidate trumor suppressor gene implicated in prostate cancer. J. Urol. 145:294A. Buttyan, R., C.A. Olsson, J. Pintar, C. Chang, M. Bandyk, P. Ng., and I.S. Sawczuk. 1989. Induction of the TRPM-2 gene in cells undergoing programmed death. Molec. and Cell Biol. 9:3473–3481. Byrne, C., J. Nedelman, and R.G. Luke. 1994. Race, socioeconomic status, and the development of end-stage renal disease. Amer. J. Kidney Dis. 23:16–22. Cagnoli, L., S. Casanova, S. Pasquali, U. Donini, and P. Zucchelli. 1980. Relation between hydrocarbon exposure and the nephrotic syndrome. BMJ 280:1068–1069. Cairns, P., A.J. Proctor, and M.A. Knowles. 1991. Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma. Oncogene 6:2305–2309. Cantrell, B.B., D.P. DeKlerk, J.C. Eggleston, J.K. Boitnott, and P.C. Walsh. 1981. Pathological factors that influence prognosis in state A prostatic cancer: The influence of extent versus grade. J. Urol. 125:516–520. Capella, C., L. Usellini, R. Buffa, B. Frigerio, and e. Solcia. 1981. The endocrine component of prostatic carcinomas, mixed adenocarcinoid tumours and non-tumour prostate: Histochemical and ultrastructural identification of the endocrine cells. Histopathology 5:175–192. Carbin, B.E., P. Ekman, P. Eneroth, and B. Nilsson. 1989. Urine-TPA (tissue polypeptide antigen), flow cytometry and cytology as markers for furnor invasiveness in urinary bladder carcinoma. Urol. Res. 17:269–272. Carlisle, E.J., S.M. Donnelly, S. Vasuvattakul, K.S. Kamel, S. Tobe, and M.L. Halperin.

OCR for page 227
Biologic Markers in Urinary Toxicology Tsau, Y.K., J.T. Norman, and L.G. Fine. 1989. Epidermal growth factor (EGF) enhances renal regeneration and accelerates recovery, from ischemic acute renal failure [abstract]. Kidney Int. 35:420. Tsukamoto, T., Y. Kumamoto, K. Yamazaki, T. Umehara, N. Miyao, K. Ohmura, and M. Iwazawa. 1988. Clinical study of tumor markers in prostatic carcinoma--an investigation on the simultaneous measurement of prostatic acid phosphatase (PAP), prostatic antigen (PA) and gamma-seminoprotein (gamma-Sm) [in Japanese] Hinyokika Kiyo (Acta Urol. Jpn.) 34:987–995. Tucker, B.J. and Blantz. 1977. Factors determining superficial nephron filtration in the mature, growing rat. Am. J. Physiol. 232:F97. Tune, B.M. 1986. The nephrotoxicity of cephalosporin antibiotics-Structure-activity relationships. Comments Toxicol. 1:145–170. Tupper, J.T., F. Zorgniotti, and B. Mills. 1977. Potassium transport and content during G1 and S phase following serum stimulation of 3T3 cells. J. Cell Physiol. 91:429–440. Turbat-Herrera, E.A., G.A. Herrera, I. Gore, R.L. Lott, W.E. Grizzle, and J.M. Bonnin. 1988. Neuroendocrine differentiation in prostatic carcinomas: A retrospective autopsy study. Arch. Pathol. Lab. Med. 112:1100–1106. Tyson, C.K., and J.C. Mirsalis. 1985. Measurement of unscheduled DNA synthesis in rat kidney cells following in vivo treatment with genotoxic agents. Environ. Mutagen. 7:889–899. Uchida, T., K. Shinohara, K. Kobayashi, N. Honda, T. Ao, T. Omata, K. Odajima, and K. Koshiba. 1986. Tumor markers in renal cell carcinoma [in Japanese] . Hinyokika Kiyo, (Acta Urol. Jpn.) 32:929–940. Ullrich, K.J., and G. Rumrich. 1993. Renal transport mechanisms for xenobiotics: Chemicals and drugs. Clin. Invest. 71:843–848. Ulrich, K.J., G. Rumrich, T. Wieland, and W. Dekant. 1989. Contraluminal para-aminohippurate (PAH) transport in the proximal tubule of rat kidney. VI. Specificity: Amino acids, their N-methyl-, N-acetyl-, and N-benzoyl derivatives; glutathione-and cysteine conjugates, di-and oligopeptides. Pflfgers Arch. 415:342–350. (Chapter 3) Umbas, R., J.A. Schalken, T.W. Aalders, B.S. Carter, H.F.M. Karthaus, H.E. Schaafsma, F.M.J. Debruyne, and W.B. Isaacs. 1992. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res. 52:5104–5109. Unger, P.D., C.W. Watson, Z. Liu, and J. Gil. 1993. Morphometric analysis of neoplastic renal aspirates and benign renal tissue. Anal. Quant. Cytol. Histol. 15:61–66. USRDS (United States Renal Data System). 1991, United States Renal Data System, USRDS 1991 Annual Report, Bethesda, MD , The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, August 1991.

OCR for page 227
Biologic Markers in Urinary Toxicology USRDS (United States Renal Data System). 1993. Annual Report. Valles, A., G. Tucker, J. Thiery, and B. Boyer. 1990. Alternative patterns of mitogenesis and cell scattering induced by acidic FGF as a function of cell density in a rat bladder carcinoma cell line. Cell Regul. 1:975–988. Vamvakas, S., A. Küchling, K. Berthold, and W. Dekant. 1989a. Cytotoxicity of cysteine S-conjugates: Structure-activity relationships. Chem.-Biol. Interact. 71:79–90. Vamvakas, S., W. Dekant, and M.W. Anders. 1989b. Mutagenicity of benzyl S-haloalkyl and S–74 haloalkenyl Sulfides in the Ames test. Biochem. Pharmacol. 38:935–939. Vamvakas, S., W. Dekant, and D. Henschler. 1989c. Assessment of unscheduled DNA synthesis in a cultured line of renal epithelial cells exposed to cysteine S-conjugates of haloalkanes and haloalkenes. Mutation Res. 222:329–335. Vamvakas, S., M. Herkenhoff, W. Dekant, and D. Henschler. 1989d. Mutagenicity of tetrachloroethene in the Ames test--metabolic activation by conjugation with glutathione. J. Biochem. Toxicol. 4:21–27. van Dalen, A., D.H. Helmhout, and R.D. van Caubergh. 1988. The contribution of prostatic acid phosphatase and prostatic specific antigen in the diagnosis of prostatic cancer. Int. J. Biol. Markers 3:123–126. vanden Houte, K., R. Kiss, C. de Prez, A. Verhest, J.L. Pasteels, and R. Van Velthoven. 1991. Use of computerized cell image analysis to characterize cell nucleus populations from normal and neoplastic renal tissues. Eur. Urol. 19:155–164. van der Hout, A.H., E. van den Berg, P. van der Vlies, T. Dijkhuizen, S. Storkel, J.W. Oosterhuis, B. de Jong, and C.H. Buys. 1993. Loss of heterozygosity at the short arm of chromosome 3 in renal-cell cancer correlates with the cytological tumour type. Int. J. Cancer 53:353–357. van der Poel, H., M. Boon, L. Kok, E. van der Meulen, R. van Caubergh, et al. 1991. Morphometry, densitometry and pattern analysis of plastic-embedded histologic material from urothelial) cell carcinoma of the bladder. Anal. Quant. Cytol. Histol. 13:307–315. van Dierendonck, J., J. Wijsman, R. Keijzer, C.H. van de Velde, and C. Cornelisse. 1991. Cell-cycle-related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Am. J. Pathol. 138:1165–1172. Vandoren, G., B. Mertens, W. Heyns, H. Van Baelen, W. Rombauts, and G. Verhoeven. 1983. Different forms of α2u-globulin in male and female rat urine. Eur. J. Biochem. 134:175–181. van Leeuwen, E.H., A. Postma, J.W. Oosterhuis, A. Meiring, C.J. Cornelisse, J. Koudstaal, W.M. Molenaar. 1987. An analysis of histology and DNA-ploidy in primary wilms tumors and their metastases and a study of the morphological effects of therapy. Virchows Arch. A: Pathol. Anat. Histopathol. 410:487–494. van Weerden, W.M., E.P. Moerings, A. van Kreuningen, F.H. de Jong, G.J. van

OCR for page 227
Biologic Markers in Urinary Toxicology Steenbrugge, and F.H. Schroeder. 1993. Ki-67 expression and BrdUrd incorporation as markers of proliferative activity in human prostate tumour models. Cell Prolif. 26:67–75. Vancura, P., L. Miller, J.W. Little, and R.A. Malt. 1970. Contribution of glomerular and tubular RNA synthesis to compensatory renal growth. Am. J. Physiol. 219:78–83. Veloso, J.D., O.G. Solis, J.H. Barada, H.A. Fisher, and J.S. Ross. 1992. DNA ploidy of oncocytic-granular renal cell carcinomas and renal oncocytomas by image analysis. Arch. Pathol. Lab. Med. 116:154–158. Verpooten, G.F., E.J. Nouwen, M.F. Hoylaerts, P.G. Hendrix, and M.E. De Broe. 1989. Segment-specific localization of intestinal-type alkaline phosphatase in human kidney. Kidney Int. 36:617–625. Verstrepen, W., E.J. Nouwen, Y. Ziaosheng, and M. De Broe. 1991. Expression of EGF, TGF-alpha, and PDGF-A in the rat kidney during regeneration after acute aminoglycoside toxicity. JASN 2:447A. Viau, C., A. Bernard, R. Lauwerys, J.P. Buchet, L. Quaeghebeur, M.E. Cornu, S.C. Phillips, A. Mutti, S. Lucertini, and 1. Franchini. 1987, A cross sectional survey of kidney function in oil refinery employees. Am. J. Ind. Med. 11:177–187. Vinay, P., A. Gougoux, and G. Lemieux. 1981. Isolation of a pure suspension of rat proximal tubules. Am. J. Physiol. 241: F403-F411. Visakorpi, T., O.P. Kallioniemi, I.Y. Paronen, J.J. Isola, A.I. Heikkinen, and T.A. Koivula. 1991. Flow cytometric analysis of DNA ploidy and S-phase fraction from prostatic carcinomas: Implications for prognosis and response to endocrine therapy. Br. J. Cancer 64:578–582. Voeller, H., G. Wilding, and E. Gelmann. 1991. v-rasH expression confers hormone-independent in vitro growth to LNCaP prostate carcinoma cells. Mol. Endicrol 5:209–216. Volm, M., and T. Efferth. 1990. Relationship of DNA ploidy to chemoresistance of tumors as measured by in vitro tests. Cytometry 11:406–410. Volm, M., M. Kastel, J. Mattern, and T. Efferth. 1993. Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas . Cancer 71:3981–3987. Vonder Hude, W., A. Basler, R. Mateblowski, and G. Obe. 1989. Genotoxicity of epoxides II. In vitro investigations with the sister chromatid exchange (SCE) test and the unscheduled DNA synthesis (UDS) test. Mutagenesis 4:323. Vuitch, M.F.; Mendelsohn, G. Relationship of ectopic ACTH production to tumor differentiation: a morphologic and immunohistochemical study of prostatic carcinoma with Cushing's syndrome.. Cancer 47:296–299; 1981. Waber, P.G., J. Chen, and P.D. Nisen. 1993. Infrequency of ras, p53, WTI, or RB gene alterations in Wilms tumors. Cancer 72:3732–3738.

OCR for page 227
Biologic Markers in Urinary Toxicology Wade, T.P., L.G. Comelia, E.R. Sargent, P. Anglard, A. Kasid, and W.M. Linehan. 1989. Southern blot analysis of transformed growth factor alpha and beta DNA in normal kidney and in renal cell carcinoma. Curr. Surg. 46:401–403. Waldmann, T.A., W. Strober, and R.P. Mogielnicki. 1972. The renal handling of low molecular weight proteins. J. Clin. Invest. 51:2162. Waldman, F.M., P.R. Carroll, R. Kerschmann, M.B. Cohen, F.G. Field, and B.H. Mayall. 1991. Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer. Cancer Res. 51:3807–3813. Waldman, F.M., P.R. Carroll, M.B. Cohen, R. Kerschmann, K. Chew, and B.H. Mayall. 1993. 5-Bromodeoxyuridine incorporation and PCNA expression as measures of cell proliferation in transitional cell carcinoma of the urinary bladder. Mod. Pathol. 6:20–24. Walker, R.J., and G.G. Duggin. 1988. Drug nephrotoxicity. Annu. Rev. Pharmacol. Toxicol. 28:331–345. Walker, K.Z., P.J. Russell, E.A. Kingsley, J. Philips, and D. Raghavan. 1989. Detection of malignant cells in voided urine from patients with bladder cancer, a novel monoclonal assay. J. Urol, 142:1578–1583. Walker, C., L. Recio, K. Funaki, and J. Everitt. 1992. Cytogenetic and molecular correlates between rodent and human renal cell carcinoma [review] . Prog. Clin. Biol. Res. 376:289–302. Wallace, A.C., and R.C. Nairn. 1972. Renal tubular antigens in kidney tumors. Cancer 29:977–981. Wallin, A., R.G. Gerdes, R. Morgenstern, T.W. Jones, and K. Ormstad. 1988. Features of microsomal and cytosolic glutathione conjugation of hexachlorobutadiene in rat liver. Chem.-Biol. Interact. 68: 1–11. Wallin, A., G. Zhang, T. Jones, S. Jaken, and J. Stevens. 1992. Mechanism of the nephrogenic repair response. Lab. Invest. 66:474–484. Walzer, M. 1982. Delay of progression of renal failure. Pp. 23–30 in Prevention of Kidney Disease and Long-Term Survival, M.M. Avram, ed. New York: Plenum. Wang, Z. 1991. Oncogene ras P 21 expression and DNA ploidy in human bladder tumor [in Chinese]. Zhonghua Zhongliu Zazhi 13:245–248. Wang, T., and T. Kawaguchi. 1987. Preliminary evaluation of measurement of serum prostate-specific antigen level in detection of prostate cancer. Ann. Clin. Lab. Sci. 16:461–466. Wang, M.C., L.A. Valenzuela, G.P. Murphy, and T.M. Chu. 1979. Purification of a human prostate specific antigen. Invest. Urol. 17:159–63. Watanabe, T., A. Hiratusuka, M. Isobe, and N. Ozawa. 1980. Metabolism of d-Limonene by hepatic microsoms to monmutagenic epoxides toward salmonella typhimurium. Biochem. Pharmacol. 29:1068. Watanabe, M., Y. Kitamura, S. Komatsubara, and Y. Sakata. 1988. Role of

OCR for page 227
Biologic Markers in Urinary Toxicology gamma-seminoprotein (gamma-SM) and prostatic acid phosphatase (PAP) as tumor markers of prostatic cancer [in Japanese]. Hinyokika Kiyo (Acta Urol. Jpn.) 34:2135–2141. Waters, W.B., and J.P. Richie. 1979. Aggressive surgical approach to renal cell carcinoma. Review of 130 cases. J. Urol. 122:306–309. Weaver, M.G., F.W. Abkul-Karim, J. Strigley, D.G. Bostwick, J.Y. Ro, and A.G. Ayala. 1992. Paneth cell-like change of the prostate gland. A histological, immunohistochemical, and electron microscopic study. Am. J. Surg. Pathol. 16:62–68. Weaver, D.J., K. Michalski, and J. Miles. 1988. Cytogenetic analysis in renal cell carcinoma: Correlation with tumor aggressiveness. Cancer Res. 48:2887–2889. Webb, D.R., G.M. Ridder, and C.L. Alden. 1989. Acute and subchronic nephrotoxicity of d-limonene in Fischer 344 rats. Food Chem. Toxicol. 27:639–649. Weber, P., and J. Rohner. 1987. Importance of acid phosphatase in response criteria for prostate cancer. Urology 30:316–317. Webster, K.D., and M.W. Anders. 1989. Bioactivation mechanism of L-thiomorpholine-3-carboxylic acid. Arch. Biochem. Biophys. 273:562–571. Webster, G.D., J.C. Touchstone, and M. Suzuki. 1959. Adenocortical hyperplasia occurring with metastatic carcinoma of the prostate: Report of a case exhibiting increased urinary aldosterone and glucocorticoid excretion. J. Clin. Endocrinol. 19:967–979. Weghorst, C.M., K.H. Dragnev, G.S. Buzard, K.L. Thorne, G.F. Vandeborne, K.A. Vincent, and J.M. Rice. 1994. Low incidence of point mutations detected in the p53 tumor suppressor gene from chemically induced rat renal mesenchymal tumors. Cancer Res. 54:215–219. Weidner, U., S. Peter, T. Strohmeyer, R. Hussnatter, R. Ackermann, and H. Sies. 1990. Inverse relationship of epidermal growth factor receptor and HER-2/neu gene expression in human renal cell carcinoma. Cancer Res. 50:4504–4509. Weinberg, J.M., J.A. Davis, M. Abarzua, T. Kiani, and R. Kunkel. 1990. Glycine-dependent protection of proximal tubules against lethal cell injury due to inhibitors of mitochondrial ATP production. Am. J. Physiol. 258:C1127–C1140. Weiss, R. 1989. Predisposition and prejudice. Sci. News 135:40–42. Weiss, L.M., M.J. Gaffey, M.J. Warhol, P. Mehta, S.M. Bonsib, E. Bruder, E. Santos, and L.J. Mederios. 1991. Immunocytochemical characterization of a monoclonal antibody directed against mitochondria reactive in paraffin-embedded sections . Mod. Pathol. 4:596–601. Wells, D., B. Bennett, and W.J. Gardner. 1985. Uses and limitations of prostate-specific antigen in the laboratory, diagnosis of prostate cancer. South. Med. J. 81 Wenk, R.E., B.S. Bhagavan, R. Levy, D. Miller, and W. Weisburger. 1977. Ectopic

OCR for page 227
Biologic Markers in Urinary Toxicology ACTH, prostatic oat cell carcinoma, and marked hypernatremia. Cancer 40:773–778. Werber, A., S.N. Emancipator, M.L. Lykocinski, and J.R. Sedor. 1987. The interleukin 1 gene is expressed by rat glomerular mesangial cells and is augmented in immune complex glomerulonephritis. J. Immunol. 138:3207–3212. Wernert, N., M.B. Raes, P. Lassalle, M.P. Dehouck, B. Gosselin, B. Vandenbunder, and D. Stehelin. 1992. c-etsl proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am. J. Pathol. 140:119–127. West, S.S. 1970. Biophysical Cytochemistry. Page 451 in Introduction to Quantitative Cytochemistry , Vol. II, G.L. Weid, and G.F. Bahr, eds. New York: Academic Press. West, S.S., G.P. Hemstreet, R.E. Hurst, et al. 1987. Detection of DNA aneuploidy by quantitative fluorescence image analysis: Potential in screening for occupational bladder cancer. Pp. 327–341 in Biological Monitoring of Exposure to Chemicals, Vol. I. Organic Chemicals, H.K. Dillon, and M. Ho, eds. New York: Wiley. Wheeless, L.L., J. Coon, C. Cox, A. Deitch, R.W. DeVere White, et al. 1991. Precision of DNA flow cytometry in inter-institutional analyses. Cytometry 12:405–412. Wheeless, L.L., R.A. Badalament, R.W. DeVere White, Y. Fradet, and B. Tribukait. 1993. Consensus review of the clinical utility of DNA cytometry in bladder cancer. Cytometry 14:478–481. Wibel, L., and A. Karlsson. 1976. Urinary excretion of β2-microglobulin after the induction of a diuresis. A study in healthy subjects. Nephron 17:343–352. Wiggins, R.C., A. Glatfelter, and J. Brukman. Procoagulant activity in glomeruli and urine of rabbits with nephrotoxic nephritis. Lab. Invest. 53:156–165. Wille, J.J., J. Park, and A. Elgavish. 1992. Effects of growth factors, hormones, bacterial lipopolysaccharides, and lipotechoic acids on the clonal growth of normal ureteral epithelial cells in serum-free culture. J. Cell Physiol. 150:52–58. Willems, M., H. Musilova, and R.A. Malt. 1969. Giang nucleoplasmic RNA in ''switch on'' of compensatory renal growth, Proc. Natl. Acad. Sci. U.S.A. 62:1189–1194. Wilson, C.B. 1982. Drug-and toxin-induced nephrotodes: Anti-kidney antibody and immune complex mediation. Pp. 383–392 in Nephrotoxic Mechanisms of Drugs and Environmental Toxins, G.A. Porter, ed. New York: Plenum. Wilson, P.D., R.J. Anderson, R.D. Breckon, W. Nathrath, and R.W. Schrier. 1987. Retention of differentiated characteristics by cultures of defined rabbit kidney epithelia. J. Cell. Physiol. 130:245–254. Wise, H.M., A.L. Fohl, A. Gazzaniga, J.H. Harrison. 1965. Hyperadrenocorticism associated with "reactivated" prostatic carcinoma. Surgery 57:655–664. Wolf, G., and E.G. Neilson. 1990. Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells. Am. J. Physiol. 259:F768–F777.

OCR for page 227
Biologic Markers in Urinary Toxicology Wolf, G., and E.G. Neilson. 1991. Molecular mechanisms of tubulointerstitial hypertrophy and hyperplasia. Kidney Int. 39:401–420. Wolff, G., P.D. Killen, and E.G. Neilson. 1990. Cyclosporin A stimulates transcription and procollagen secretion in tubulointerstitial fibroblasts and proximal tubular cells. J. Am. Soc. Nephrol. 1:918–922. Wolfgang, G.H.I., A.J. Gandolfi, J.L. Stevens, and K. Brendel. 1989, N-Acetyl S-(1,2-dichlorovinyl)-L-cysteine produces a similar toxicity to S-(1,2-dichlorovinyl)-L-cysteine in rabbit renal slices: Differential transport and metabolism. Toxicol. Appl. Pharmacol. 101:205–219. Wood, D.P., D.D. Wartinger, V. Reuter, C. Cordon-Cardo, W.R. Fair, and R.S. Chaganti. 1991. DNA, RNA and immunohistochemical characterization of the HER-2/neu oncogene in transitional cell carcinoma of the bladder. J. Urol. 146:1398–1401. Wood, D.P., W.R. Fair, and R.S. Chaganti. 1992. Evaluation of epidermal growth factor receptor DNA amplification and mRNA expression in bladder cancer. J. Urol. 147:274–277. Woolf, C.M. 1960. An investigation of the familial aspects of carcinoma of the prostate. Cancer 13:739–744. Woolhandler, S., R.J. Pels, D.H. Bor, D.U. Himmelstein, and R.S. Lawrence. 1989. Dipstick urinalysis of asymptomatic adults for urinary tract disorders. I. Hematuria and proteinuria. JAMA 262:1214–1219. Wright, C., K. Mellon, P. Johnston, D.P. Lane, A.L. Harris, C.H. Horne, and D.E. Neal. 1991. Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder. Br. J. Cancer 63:967–970. Wu, S.-Q., B.E. Storer, E.A. Bookland, A.J. Klingelhutz, K.W. Gilchrist, L.F. Meisner, R. Oyasu, and C.A. Reznikoff. 1991. Nonrandom chromosome losses in stepwise neoplastic transformation in vitro of human uroepithelial cells. Cancer Res. 51:3323–3326. Wuthrich, R., M.A. Yui, G. Mazoujian, N. Nabavi, L.H. Glimcher, and V.E. Kelley. 1989. Enhanced MHC class II expression in renal proximal tubules precedes loss of renal function in MRL/lpr mice with lupus nephritis. Am. J. Path. 134:45–51. Wuthrich, R.P., A.M. Jevnikar, F. Takei, L.H. Glimcher, and V.E. Kelley. 1990. Intercellular adhesion molecule-1 (ICAM-l) expression is preregulated in autoimmune murine lupus nephritis. Am. J. Path. 136:441–450. Yagoda, A., and N.H. Bander. 1989. Failure of cytotoxic chemotherapy, 1983–1988, and the emerging role of monoclonal antibodies for renal cancer [review]. Urol. Int. 44:338–345. Yamada, T., I. Fukui, T. Kobayashi, H. Sekine, M. Yokogawa, and H. Oshima. 1991. The relationship of ABH(O) blood group antigen expression in intraepithelial

OCR for page 227
Biologic Markers in Urinary Toxicology dysplastic lesions to clinicopathologic properties of associated transitional cell carcinoma of the bladder. Cancer 67:1661–1666. Yamakawa, K., R. Morita, E. Takahashi, T. Hori, J. Ishikawa, and Y. Nakamura. 1991. A detailed deletion mapping of the short arm of chromosome 3 in sporadic renal cell carcinoma. Cancer Res. 51:4707–4711. Yamamoto et al. 1994. Yamazaki, K., Y. Kumamoto, T. Tsukamoto, K. Ohmura, N. Miyao, and T. Yoshioka. 1988. The clinical investigation of tumor markers for renal cell carcinoma--a comparison among TPA, ferritin and immunosuppressive substance [in Japanese]. Nippon Hinyokika Gakkai Zasshi (Jpn. J. Urol.) 79:28–34. Yamazaki, K., Y. Kumamoto, T. Tsukamoto, K. Ohmura, N. Miyao, M. Yoshioka, A. Iwasawa. 1991. Immunosuppressive acidic protein (IAP) and immunosuppressive substance (ISS) in patients with renal cell carcinoma (in Japanese). Hinyokika Kiyo (Acta Urol. Jpn.) 37:467–474. Yao, M., T. Shuin, H. Misaki, and Y. Kubota. 1988. Enhanced expression of c-myc and epidermal growth factor receptor (C-erbB-1) genes in primary human renal cancer. Cancer Res. 48:6753–6757. Yaqoob, M., and G.M. Bell. 1994. Occupational factors and renal disease. Renal Failure 16:425–434. Yaqoob, M., G.M. Bell, D. Perdy, and R. Finn. 1992a. Primary glomerulonephritis and hydrocarbon exposure: A case control study and literature review. Q. J. Med. 301:409–418. Yaqoob, M., A.W. Patrick, P. McClelland, A. McGregor, H. Mason, M.C. White, and G.M. Bell. 1992b. High hydrocarbon exposure in diabetic nephropathy. Nephrol. Dial. Transplant. 8:1157–1158. Yaquoob, M., A. Stevenson, H. Mason, and G.M. Bell. 1993. Hydrocarbon exposure and tubular damage: Additional factors in the progression of renal failure in primary glomerulonephritis. Q. J. Med. 86:661–667. Yogi, S., T. Ikeuchi, H. Yoshikawa, T. Hamashima, H. Sasaki, F. Morikawa, Y. Onodera, K. Matsumoto, and Y. Kai. 1991. Clinical evaluation of the bladder tumor marker "Tu-MARK-BTA" [in Japanese]. Hinyokika Kiyo (Acta Urol. Jpn.) 37:335–339. Yorimitsu, K., O. Shinmi, M. Nishiyama, K. Moroi, Y. Sugita, T. Saito, Y. Inagaki, T. Masaki, and S. Kimura. 1992. Effect of phosphoramidon on big endothelin-2 conversion into endothelin-2 in human renal adenocarcinoma (ACHN) cells. Analysis of endothelin-2 biosynthetic pathway. FEBS Lett. 314:395–398. Yoshida, S.O., A. Imam, C.A. Olson, and C.R. Taylor. 1986. Proximal renal tubular surface membrane antigens identified in primary and metastatic renal cell carcinomas. Arch. Pathol. Lab. Med. 110:825–832. Yoshida, M.A., T. lkeuchi, Y. Tachibana, K. Takagi, M. Moriyama, and A. Tonomura.

OCR for page 227
Biologic Markers in Urinary Toxicology 1988. Rearrangements of chromosome 3 in nonfamilial renal cell carcinomas from Japanese patients. Jpn. J. Cancer Res. 79:600–607. Yoshiki, T., K. Okada, K. Oishi, and O. Yoshida. 1987. Clinical significance of tumor markers in prostatic carcinoma--comparative study of prostatic acid phosphatase, prostate specific antigen and gamma-seminoprotein [in Japanese] . Hinyokika Kiyo, (Acta Urol. Jpn.) 33:2044–2049. Yoshimura, A., K. Gordon, C.E. Alpers, J. Floege, P. Pritzl, R. Ross, W.G. Couser, D.F. Bowen-Pope, and R.J. Johnson. 1991. Demonstration of PDGF B-chain mRNA in glomeruli in mesangial proliferative nephritis by in situ hybridization. Kidney Int. 40: 470–476. Yoshioka, K., T. Takemura, M. Tohda, N. Akano, H. Miyamoto, A. Ooshima, and S. Maki. 1989. Glomerular localization of type III collagen inhuman kidney disease. Kidney Int. 35:1203–1211. Young, D.A., G.R. Prout, and C.-W. Lin. 1985. Production and characterization of mouse monoclonal antibodies to human bladder-tumor associated antigens. Cancer Res. 45:4439–4446. Young, E.W., E.A. Mauger, K-H. Jiang, F.K. Port, and R.A. Wolfe. 1994. Socioeconomic status and end-stage renal disease in the United States. Kidney Int. 45:907–911. Yu, D.S., J. Wang, S.Y. Chang, and C.P. Ma. 1991. Flow cytometric analysis of DNA ploidy, cell cycle and cytomorphometry in sarcomatoid renal cell carcinoma. Eur. Urol. 20:227–231. Yu, D.S., C.M. Hsu, W.H. Lee, S.Y. Chang, and C.P. Ma. 1993. Flow cytometric DNA and cytomorphometric analysis in renal cell carcinoma: Its correlation with histopathology and prognosis. J. Surg. Res. 55:480–485. Yun, S.K., D.J. Laub, D.L. Weese, P.M. Lad, G.E. Leach, and P.E. Zimmern. 1992. Stimulated release of urine histamine in interstitial cystitis. J. Urol. 148:1145–1148. Yura, Y., O. Hayashi, M. Kelly, and R. Oyasu. 1989. Identification of epidermal growth factor as a component of the rat urinary bladder tumor-enhancing urinary fractions. Cancer Res. 49:1548–1553. Zager, R.A. 1988. Gentamicin nephrotoxocity in the setting of renal hypoperfusion. Am. J. Physiol. 254:F574–F581. Zager, R.A., and H.M. Sharma. 1983. Gentamicin increases renal susceptibility to an acute ischemic insult. J. Lab. Clin. Med. 101:670. Zager, R.A., and M.A. Venkatachalam. 1983. Potentiation of ischemic renal injury by amino acid infusion. Kidney Int. 24:620–625. Zalups, R.K., and L.H. Lash. 1990. Effects of uninephrectomy and mercuric chloride on renal glutathione homeostasis. J. Pharmacol. Exp. Ther. 254:962–970. Zalups, R.K., and J.C. Veltman. 1988. Renal glutathione homeostasis in compensatory renal growth. Life Sci. 42:2171–2176. Zalups, R.K., K.L. Knutson, and R.G. Schnellmann. 1993. In vitro analysis of the

OCR for page 227
Biologic Markers in Urinary Toxicology accumulation and toxicity of inorganic mercury in segments of the proximal tubule isolated from the rabbit kidney. Toxicol. Appl. Pharmacol. 119:1–7. Zenser, T.V., and B.B. Davis. 1984. Enzymes systems involved in the formation of reactive metabolites in the renal medulla: Cooxidation via prostaglandin H synthase. Fund. Appl. Toxicol. 4:922–929. Zhang, G., and J.L. Stevens. 1989. Transport and activation of S-(1,2-dichlorovinyl)-L-cysteine and N-acetyl-S-(1,2-dichlorovinyl)-L-cysteine in rat kidney proximal tubules. Toxicol. Appl. Pharmacol. 100:51-61. Zimmerman, S.W., K. Groehler, and G.J. Beirne, 1975. Hydrocarbon exposure and chronic glomerulonephritis. Lancet 2:199–202. Zoja, C., N. Perico and G. Remuzzi. 1989. Abnormalities in arachidonic acid metabolites in nephrotoxic glomerular injury. Toxicol. Lett. 46:65–75. Zumkeller, W., J. Schwander, C.D. Mitchell, D.J. Morrell, P.N. Schofield, and M.A. Preece. 1993. Insulin-like growth factor (IGF)-I,-II and IGF binding protein-2 (IGFBP-2) in the plasma of children with Wilms' tumour. Eur. J. Cancer 29A: 1973–1977.

OCR for page 227